MEI Pharma, Inc. (MEIP) Financials
Stock symbol MEIP is outdated, potentially delisted? Maybe it is available on other exchange?
MEIP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | 71.3 million | 20.2 million |
| Dec. 31, 2023 | 78.5 million | 19.1 million |
| Sept. 30, 2023 | 101.3 million | 19.9 million |
| June 30, 2023 | 120.8 million | 96.2 million |
MEIP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | -2.9 million | ? |
| Dec. 31, 2023 | -11.1 million | 850000 |
| Sept. 30, 2023 | -18.5 million | 363000 |
| June 30, 2023 | -11.3 million | 299000 |
MEIP Net Income
No data available :(
MEIP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 56.6 million | - | - |
| Dec. 31, 2023 | 59.5 million | - | 12.0 million |
| Sept. 30, 2023 | 82.2 million | - | 12.4 million |
| June 30, 2023 | 100.7 million | - | 12.7 million |
MEIP Shares Outstanding
MEIP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | - | 5.2 million | 4.6 million | -86000 |
| Dec. 31, 2023 | 7000 | 3.9 million | 8.0 million | -85000 |
| Sept. 30, 2023 | 7000 | 3.5 million | 6.5 million | - |
| June 30, 2023 | 28000 | 2.6 million | 10.0 million | - |
MEIP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | - | 86000 |
| Dec. 31, 2023 | - | 85000 |
| Sept. 30, 2023 | 65.3 million | 459000 |
| June 30, 2023 | 1.5 million | 464000 |
MEIP
Price: $3.07
52 week price:
Earnings Per Share: -4.75 USD
P/E Ratio: -0.95
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 480786
Ebitda: -6.2 millionMarket Capitalization: 30.2 million
Average Dividend Frequency: 1